NeuroMetrix, Inc. (NURO) Financials

NURO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 21.3 million 1.4 million
2023-06-30 22.8 million 1.4 million
2023-03-31 23.6 million 1.6 million
2022-12-31 24.7 million 1.3 million

NURO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.2 million 221268
2023-06-30 -1.5 million 132745
2023-03-31 -1.1 million 165361
2022-12-31 -1.5 million 168139

NURO Net Income

No data available :(

NURO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 17.6 million - 122870
2023-06-30 19.6 million - 152143
2023-03-31 20.3 million - 180345
2022-12-31 21.2 million - 207516

NURO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 8.5 million
2023-06-30 7.8 million
2023-03-31 7.9 million
2022-12-31 7.8 million

NURO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 138176 592654 1.2 million 943795
2023-06-30 - 753509 1.2 million 744963
2023-03-31 - 699425 1.4 million 815872
2022-12-31 13432 538395 918214 629969

NURO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.2 million 421382
2023-06-30 1.7 million 536486
2023-03-31 1.7 million 526372
2022-12-31 1.8 million 617267

NURO

Price: $4.60

52 week price:
2.70
12.08

Earnings Per Share: -6.27 USD

P/E Ratio: -0.59

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 39500

Ebitda: -2.8 million

Market Capitalization: 7.8 million

Links: